Ruthenium(II) Lipid‐Mimics Drive Lipid Phase Separation to Arouse Autophagy‐Ferroptosis Cascade for Photoimmunotherapy
Advanced Science · 2025
DOI: 10.1002/advs.202411629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yue Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Development, IGCME, GBRCE for Functional Mole…. Hauptthemen laut MEDLINE: Ferroptosis, Ruthenium, Autophagy, Immunotherapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Guangzhou Science and Technology Plan Project.
Abstract (Originalsprache)
Lipid‐mediated phase separation is crucial for the formation of lipophilic spontaneous domain to regulate lipid metabolism and homeostasis, furtherly contributing to multiple cell death pathways. Herein, a series of Ru(II) lipid‐mimics based on short chains or midchain lipids are developed. Among them, Ru‐LipM with two dodecyl chains significantly induces natural lipid phase separation via hydrocarbon chain‐melting phase transitions. Accompanied by the aggregation of Ru‐LipM ‐labeled lipophilic membrane‐less compartments, most polyunsaturated lipids are increased and the autophagic flux is retarded with the adaptor protein sequestosome 1 (p62). Upon low‐dose irradiation, Ru‐LipM further drives ferritinophagy, providing an additional source of labile iron and rendering cells more sensitive to ferroptosis. Meanwhile, the peroxidation of polyunsaturated lipids occurs due to the deactivation of glutathione peroxidase 4 (GPX4) and the overexpression of acyl‐CoA synthetase long‐chain family member 4 (ACSL4), leading to the immunogenic ferroptosis. Ultimately, both innate and adaptive immunity are invigorated, indicating the tremendous antitumor capability of Ru‐LipM in vivo. This study presents an unprecedented discovery of small molecules capable of inducing and monitoring lipid phase separation, thereby eliciting robust immune responses in living cells. It provides a biosimulation strategy for constructing efficient metal‐based immune activators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Development, IGCME, GBRCE for Functional Molecular Engineering, School of Chemistry, Sun Yat-Sen University, Guangz…
- Guangdong Province Key Laboratory of Pharmaceutical Bioactive Substances, School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, P. R. China.
ORCID-Profile: Yue Zheng, Kun Peng, Zong-Wan Mao
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Guangzhou Science and Technology Plan Project
- Fundamental Research Funds for the Central Universities
- Guangdong Basic and Applied Basic Research Foundation
- National Key Research and Development Program of China
Zitieren
APA
Zheng, Y., Wang, W. J., Chen, J. X., Peng, K., Chen, X. X., Shen, Q. H., Liang, B. B., Mao, Z. W., & Tan, C. P. (2025). Ruthenium(II) Lipid‐Mimics Drive Lipid Phase Separation to Arouse Autophagy‐Ferroptosis Cascade for Photoimmunotherapy. Advanced Science. https://doi.org/10.1002/advs.202411629
Vancouver
Zheng Y, Wang WJ, Chen JX, Peng K, Chen XX, Shen QH, et al. Ruthenium(II) Lipid‐Mimics Drive Lipid Phase Separation to Arouse Autophagy‐Ferroptosis Cascade for Photoimmunotherapy. Advanced Science. 2025. doi:10.1002/advs.202411629
BibTeX
@article{Zheng2025,
author = {Zheng, Yue and Wang, Wen-Jin and Chen, Jing-Xin and Peng, Kun and Chen, Xiao-Xiao and Shen, Qing-Hua and Liang, Bing-Bing and Mao, Zong-Wan and Tan, Cai-Ping},
title = {Ruthenium(II) Lipid‐Mimics Drive Lipid Phase Separation to Arouse Autophagy‐Ferroptosis Cascade for Photoimmunotherapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202411629}
}
EUVIMED